Synlogic has announced it has secured $40 million in series B financing.
Synlogic, based in Cambridge, Mass., is a biopharmaceutical company focused on the development of a class of therapeutics, called synthetic...more
Atreca has announced it has secured $56 million in series A funding.
Atreca, based in Redwood City, California, is a privately held biotechnology company developing therapeutics drawn from human immune responses,...more
AMO Pharma Limited has announced it has secured $25 million in private equity financing.
AMO Pharma, with offices in Philadelphia and London, is a privately held biopharmaceutical company focusing on debilitating...more
Intellia, based in Cambridge, Mass., is gene editing company focused on the development of curative medicines utilizing a developed biological tool known as the CRISPR/Cas9 system....more
Metacrine, based in San Diego, Calif., is a biotechnology company focused on advancing research in nuclear hormone receptors for treatment of metabolic diseases originated at the Salk Institute for Biological Studies....more
Spirox has announced it has secured $18.5 million in series B funding.
Spirox, based in Menlo Park, Calif., develops minimally invasive technologies to treat nasal obstruction....more
Livongo, with offices in Chicago and Mountain View, Calif., is a developer of chronic disease management tools, including a cloud-enabled glucose meter....more